HAVCR2 and leukemia: Recently, the immunomodulatory effects of trogocytosis between cancer cell and immune cells were characterized through the transfer of TIM3 and CTLA4 from T cells to colorectal cancer cells and PD-1 transfer from leukemia cells to NK cells (Hasim et al., 2022; Shin et al., 2021).